Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
$8.76
+4.7%		$9.15
$3.17
▼
$11.06
$851.74M1.781.18 million shs98,676 shs
FOCL
FocalTherics
$6.25
+2.5%		$5.32
$1.21
▼
$6.40
$234.25M-0.0453,445 shs15,348 shs
InMode Ltd. stock logo
INMD
InMode
$15.23
+0.7%		$14.49
$12.72
▼
$16.74
$875.13M1.89913,200 shs142,790 shs
SiBone stock logo
SIBN
SiBone
$18.25
+0.6%		$16.53
$11.48
▼
$21.89
$808.94M0.66628,430 shs56,764 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
+3.85%+1.46%-15.73%+27.05%+120.00%
FOCL
FocalTherics
+0.16%-0.65%+14.02%+609,999,900.00%+609,999,900.00%
InMode Ltd. stock logo
INMD
InMode
-0.59%+0.13%+3.99%+8.31%+8.15%
SiBone stock logo
SIBN
SiBone
+0.55%+0.83%+4.86%+47.84%+10.54%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
$8.76
+4.7%		$9.15
$3.17
▼
$11.06
$851.74M1.781.18 million shs98,676 shs
FOCL
FocalTherics
$6.25
+2.5%		$5.32
$1.21
▼
$6.40
$234.25M-0.0453,445 shs15,348 shs
InMode Ltd. stock logo
INMD
InMode
$15.23
+0.7%		$14.49
$12.72
▼
$16.74
$875.13M1.89913,200 shs142,790 shs
SiBone stock logo
SIBN
SiBone
$18.25
+0.6%		$16.53
$11.48
▼
$21.89
$808.94M0.66628,430 shs56,764 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
+3.85%+1.46%-15.73%+27.05%+120.00%
FOCL
FocalTherics
+0.16%-0.65%+14.02%+609,999,900.00%+609,999,900.00%
InMode Ltd. stock logo
INMD
InMode
-0.59%+0.13%+3.99%+8.31%+8.15%
SiBone stock logo
SIBN
SiBone
+0.55%+0.83%+4.86%+47.84%+10.54%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
2.60
Moderate Buy$16.0082.75% Upside
FOCL
FocalTherics
2.50
Moderate Buy$9.0044.00% Upside
InMode Ltd. stock logo
INMD
InMode
2.00
Hold$16.005.09% Upside
SiBone stock logo
SIBN
SiBone
2.75
Moderate Buy$24.2933.11% Upside

Current Analyst Ratings Breakdown

Latest FOCL, INMD, SIBN, and AVR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/5/2026
SiBone stock logo
SIBN
SiBone
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/4/2026
SiBone stock logo
SIBN
SiBone
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$24.00 ➝ $25.00
8/4/2026
SiBone stock logo
SIBN
SiBone
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$18.00 ➝ $20.00
8/4/2026
SiBone stock logo
SIBN
SiBone
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$21.00 ➝ $23.00
7/28/2026
SiBone stock logo
SIBN
SiBone
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$24.00
7/28/2026
SiBone stock logo
SIBN
SiBone
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$24.00
7/21/2026
SiBone stock logo
SIBN
SiBone
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/17/2026
FOCL
FocalTherics
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetOutperform$15.00
7/17/2026
FOCL
FocalTherics
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
7/16/2026
SiBone stock logo
SIBN
SiBone
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$18.00 ➝ $21.00
7/2/2026
SiBone stock logo
SIBN
SiBone
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 8/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
$1.85M460.42N/AN/A($0.01) per share-875.50
FOCL
FocalTherics
$70.53M3.32N/AN/A$0.52 per share12.02
InMode Ltd. stock logo
INMD
InMode
$370.49M2.36$1.49 per share10.19$10.78 per share1.41
SiBone stock logo
SIBN
SiBone
$200.93M4.03N/AN/A$4.11 per share4.44
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
-$94.14M-$2.23N/AN/AN/A-5,148.78%-124.76%-101.21%8/14/2026 (Estimated)
FOCL
FocalTherics
-$29.25M-$0.81N/AN/AN/A-41.47%-137.61%-40.62%8/27/2026 (Estimated)
InMode Ltd. stock logo
INMD
InMode
$93.83M$1.2312.38N/AN/A20.69%11.83%10.49%N/A
SiBone stock logo
SIBN
SiBone
-$18.90M-$0.34N/AN/AN/A-6.85%-8.23%-6.07%N/A

Latest FOCL, INMD, SIBN, and AVR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/27/2026Q2 2026
FOCL
FocalTherics
-$0.2287N/AN/AN/A$22.48 millionN/A
8/14/2026Q2 2026
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
-$0.2073N/AN/AN/A$1.50 millionN/A
8/5/2026Q2 2026
InMode Ltd. stock logo
INMD
InMode
$0.3460$0.35+$0.0040$0.29$93.70 million$95.59 million
8/3/2026Q2 2026
SiBone stock logo
SIBN
SiBone
-$0.1495-$0.09+$0.0595-$0.09$55.34 million$56.01 million
5/12/2026Q1 2026
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
-$0.2708-$0.28-$0.0092-$0.28$0.77 million$0.49 million
5/11/2026Q1 2026
SiBone stock logo
SIBN
SiBone
-$0.17-$0.10+$0.07-$0.10$51.16 million$52.59 million
5/7/2026Q1 2026
FOCL
FocalTherics
-$0.22-$0.24-$0.02-$0.24$19.46 million$20.48 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
N/AN/AN/AN/AN/A
FOCL
FocalTherics
N/AN/AN/AN/AN/A
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
SiBone stock logo
SIBN
SiBone
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
N/A
20.93
20.93
FOCL
FocalTherics
1.79
1.34
0.99
InMode Ltd. stock logo
INMD
InMode
N/A
8.80
7.88
SiBone stock logo
SIBN
SiBone
0.20
9.15
8.34

Institutional Ownership

CompanyInstitutional Ownership
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
N/A
FOCL
FocalTherics
62.74%
InMode Ltd. stock logo
INMD
InMode
68.04%
SiBone stock logo
SIBN
SiBone
98.11%

Insider Ownership

CompanyInsider Ownership
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
4.50%
FOCL
FocalTherics
10.10%
InMode Ltd. stock logo
INMD
InMode
6.92%
SiBone stock logo
SIBN
SiBone
4.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
13897.34 million92.96 millionN/A
FOCL
FocalTherics
23037.48 million33.70 millionN/A
InMode Ltd. stock logo
INMD
InMode
48057.48 million53.50 millionOptionable
SiBone stock logo
SIBN
SiBone
35044.35 million42.58 millionOptionable

Recent News About These Companies

SiBone $SIBN Shares Purchased by Sei Investments Co.
August 7 at 4:23 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-sibone-sibn-shares-purchased-by-sei-investments-co-2026-08-07/
Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?
August 6 at 10:56 AM  |  zacks.comhttps://www.zacks.com/stock/news/2969997/does-si-bone-sibn-have-the-potential-to-rally-38-58-as-wall-street-analysts-expect?cid=cs-stocknewsapi-ft-fundamental_analysis|consensus_price_target-2969997
Insider Selling: SiBone (NASDAQ:SIBN) Director Sells $369,200.00 in Stock
August 6 at 6:36 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-sibn-insider-buying-and-selling-2026-08-06/
Renaissance Technologies LLC Increases Stake in SiBone $SIBN
August 6 at 4:32 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-renaissance-technologies-llc-increases-stake-in-sibone-sibn-2026-08-06/
SiBone (NASDAQ:SIBN) Earns Buy Rating from Truist Financial
August 6 at 2:01 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30943405
SiBone (NASDAQ:SIBN) Director Jeffrey Dunn Sells 20,000 Shares
August 5 at 7:21 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sibone-nasdaqsibn-director-jeffrey-dunn-sells-20000-shares-2026-08-05/
SiBone's (SIBN) Buy Rating Reaffirmed at Truist Financial
August 4 at 12:53 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sibones-sibn-buy-rating-reaffirmed-at-truist-financial-2026-08-04/
Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates
August 3, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2967083/si-bone-sibn-reports-q2-loss-tops-revenue-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2967083
SiBone Q2 Earnings Call Highlights
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sibone-q2-earnings-call-highlights-2026-08-03/
SiBone (NASDAQ:SIBN) Posts Earnings Results, Beats Estimates By $0.06 EPS
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sibone-nasdaqsibn-posts-earnings-results-beats-estimates-by-006-eps-2026-08-03/
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance
August 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/03/3337885/0/en/si-bone-inc-reports-financial-results-for-the-second-quarter-2026-and-raises-2026-guidance.html
SiBone (SIBN) Expected to Post Quarterly Earnings on Monday
August 2, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30935346
SiBone (NASDAQ:SIBN) Earns Buy Rating from Analysts at UBS Group
July 31, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30931907
SiBone (NASDAQ:SIBN) Rating Increased to Strong-Buy at UBS Group
July 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sibone-nasdaqsibn-rating-increased-to-strong-buy-at-ubs-group-2026-07-29/
SiBone (NASDAQ:SIBN) Shares Gap Up - Still a Buy?
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sibone-nasdaqsibn-shares-gap-up-still-a-buy-2026-07-28/
SI-BONE Inc.
July 27, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/sibn/stock-grader
SiBone (SIBN) Projected to Release Quarterly Earnings on Monday
July 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sibone-sibn-projected-to-release-quarterly-earnings-on-monday-2026-07-27/
First Light Asset Management LLC Has $67.61 Million Stock Holdings in SiBone $SIBN
July 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-first-light-asset-management-llc-has-6761-million-stock-holdings-in-sibone-sibn-2026-07-27/
Granahan Investment Management LLC Boosts Holdings in SiBone $SIBN
July 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-granahan-investment-management-llc-boosts-holdings-in-sibone-sibn-2026-07-25/
Paradigm Capital Management Inc. NY Acquires 598,300 Shares of SiBone $SIBN
July 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-paradigm-capital-management-inc-ny-acquires-598300-shares-of-sibone-sibn-2026-07-25/
SI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026
July 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/20/3330099/0/en/si-bone-to-report-second-quarter-2026-financial-results-on-august-3-2026.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Anteris Technologies Global stock logo

Anteris Technologies Global NASDAQ:AVR

$8.76 +0.40 (+4.72%)
As of 11:49 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

FocalTherics NASDAQ:FOCL

$6.25 +0.15 (+2.46%)
As of 11:31 AM Eastern

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

InMode stock logo

InMode NASDAQ:INMD

$15.22 +0.11 (+0.69%)
As of 11:48 AM Eastern
This is a fair market value price provided by Massive. Learn more.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

SiBone stock logo

SiBone NASDAQ:SIBN

$18.24 +0.11 (+0.58%)
As of 11:49 AM Eastern
This is a fair market value price provided by Massive. Learn more.

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas